Prot# ACZ EGFR 01: A Phase II, Rand, Dbl-Blind, Parallel Design Stdy to Eval ACZONE (dapsone) Gel, 5% As a Trmt for Rash Related to the Human Epidermal Growth Factor Receptor1 (HER1) /Epidermal-Growth-Factor-Receptor(EGFR) Inhibitor Tarceva® (erlotinib)
- Patel, Jyoti D (Co-PD/PI)
Project: Research project